Transforming growth factor βS: Biochemistry and biological activities in vitro and in vivo

Growth Factors and Cytokines in Health and Disease

Volumn 1, Issue C, 1996, Pages 319-356

  Cui, Wei ^a   Akhurst, Rosemary J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957048521     PISSN: 18745687     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5687(96)80015-2     Document Type: Article

References (223)

1. Abbott B.D., and Birnbaum L.S. Retinoic acid-induced alterations in the expression of growth factors in the embryonic mouse palatal shelves. Teratology 42 (1990) 597-610
2. Akhurst R.J., Fee F., and Balmain A. Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis. Nature 331 (1988) 363-365
3. Akhurst R.J., Lehnert S.A., Faissner A.J., and Duffie E. TGF-β in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108 (1990) 645-656
4. Akhurst R.J. The transforming growth factor β family in vertebrate embryogenesis. In: Nilsen-Hamilton M. (Ed). Growth Factors and Signal Transduction in Development (1994), Wiley-Liss, New York 97-122
5. Antonelli-Orlidge A., Saunders K.B., Smith S.R., and D'Amore P.A. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86 (1989) 4544-4548
6. Anzano M.A., Roberts A.B., Meyers C.A., Komoriya A., Lamb L.C., Smith J.M., and Sporn M. Synergistic interaction between two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 42 (1982) 4776-4778
7. Archer S.J., Bax A., Roberts A.B., Sporn M.B., Ogawa Y., Plez K.A., Weatherbee J., Tsang M., Lucas R., Zheng B., Wanker J., and Torchia D.A. Transforming growth factor βl: Secondary structure as determined by heteronuclear magnetic resonance spectroscopy. Biochem. 32 (1993) 1164-1171
8. Arrick B.A., Lee A.L., Grendell R.L., and Derynck R. Inhibition of translation of transforming growth factor β3 mRNA by its 5'-untranslated region. Mol. Cell. Biol. 11 (1991) 4306-4313
9. Arrick B.A., Grendell R.L., and Griffin L.A. Enhanced translational efficiency of a novel transforming growth factor β3 mRNA in human breast cancer cells. Mol. Cell. Biol. 14 (1994) 619-628
10. Arteaga C.L., Coffey Jr., Dugger T.C., McCutchen C.M., Moses H.L., and Lyons R.M. Growth stimulation of human breast cancer cells with antitransforming growth factor β antibod-ies: Evidence for negative autocrine regulation by transforming growth factor β. Cell Growth Differentiation 1 (1990) 367-374
11. Arteaga C.L., Carty-Dugger T., Moses H.L., Hurd S.D., and Pietenpol J.A. Transforming growth factor βl can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differentiation 4 (1993) 193-201
12. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., and Sporn M.B. Transforming growth factor β in human platelets Identification of a major storage site purification, and characterization. J. Biol. Chem. 258 (1983)
13. Assoian R.K., Fleurdelys B.E., Stevenson H.C., Miller P.J., Madtes D.K., Raines E.W., Ross R., and Sporn M.B. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84 (1987) 6020-6024
14. Baldwin R.L., and Korc M. Growth inhibition of human pancreatic carcinoma cells by transforming growth factor β1. Growth Factors 8 (1993) 23-34
15. Barnard J.A., Beauchamp R.D., Coffey R.J., and Moses H.L. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc. Natl. Acad. Sci. USA 86 (1989) 1578-1582
16. Barton D.E., Foellmer B.E., Du J., Tamm J., Derynck R., and Francke U. Chromosomal mapping of genes for transforming growth factors β 2 and β 3 in man and mouse: Dispersion of TGF-β gene family. Oncogene Res. 3 (1988) 323-331
17. Basson C.T., Kocher O., Basson M.D., Asis A., and Madri J.A. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β 1 correlates with reciprocal effects on cell migration. J. Cell Physiol. 153 (1992) 118-128
18. Battegay E.J., Raines E.W., Seifert F.A., Bowen-Pope D.F., and Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63 (1990) 515-524
19. Beck L.S., Chen T.L., Hirabayashi S.E., DeGuzman L., Lee W.P., McFatndge L.L., Xu Y., Bates R.L., and Ammann A.J. Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor βl. Growth Factors 2 (1990) 273-282
20. Beck L.S., Chen T.L., Mikalauski P., and Ammann A.J. Recombinant human transforming growth factor βl (rhTGF-beta 1) enhances healing and strength of granulation skin wounds. Growth Factors 3 (1990) 267-275
21. Beck L.S., DeGuzman L., Lee W.P., Xu Y., McFatridge L.A., and Amento E.P. TGF-β 1 accelerates wound healing: Reversal of steroid-impaired healing in rats and rabbits. Growth Factors 5 (1991) 295-304
22. Beck L.S., DeGuzman L., Lee W.P., Xu Y., McFatridge L.A., Gillett N.A., and Amento E.P. TGF-β induces bone closure of skull defects. J. Bone Mineral Res. 6 (1991) 1257-1265
23. Bernstein E.F., Harisiadis L., Salomon G., Norton J., Solberg S., Uitto J., Glatstein E., Glass J., Talbot T., and Russo A. Transforming growth factor β improves healing of radiation-im-paired wounds. J. Invest. Dermatol 97 (1991) 430-434
24. Bishop J.M. Molecular themes in oncogenesis. Cell 64 (1991) 235-248
25. Border W.A., Okuda S., Languino L.R., Sporn M.B., and Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor βl. Nature 346 (1990) 371-374
26. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D., and Ruoslahti E. Natural inhibitor of transforming growth factor β protects against scarring in experimental kidney disease. Nature 360 (1992) 361-364
27. Brown P.D., Wakefield L.M., Levinson A.D., and Sporn M.B. Physiochemical activation of recombinant latent transforming growth factor βl, 2, and 3. Growth factor 3 (1990) 35-43
28. Brunner A.M., Marquardt H., Malacko A.R., Lioubin M.N., and Purchio A.F. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β 1 precursor Expression and characterization of mutant proteins. J. Biol. Chem. 264 (1989) 13660-13664
29. Buchman V.L., Sporn M.B., and Davies A.M. Role of transforming growth factor β isoforms in regulating the expression of nerve growth factor and neurotrophin-3 mRNA levels in embry-onic cutaneous cells at different stages of development. Development 120 (1994) 1621-1629
30. Bursch W., Oberhammer F., Jirtle R.L., Askari M., Sedivy R., Grasl-Kraupp B., Purchio A.F., and Schulte-Hermann R. Transforming growth factor βl as a signal for induction of cell death by apoptosis. Br. J. Cancer 67 (1993) 531-536
31. Burt D.W., and Paton I.R. Evolutionary origins of the TGFβ gene family. DNA Cell Biol. 11 (1992) 497-510
32. Chakrabarty S., Jan Y., Brattain M.G., Tobon A., and Varani J. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor βl. Cancer Res. 49 (1989) 2112-2117
33. Cheifetz S., Hernandez H., Laiho M., ten Dijke P., Iwata K.K., and Massague J. Distinct transforming growth factor β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J. Biol. Chem. 265 (1990) 20533-20538
34. Cheifetz S., Bellon T., Cales C., Vera S., Bernabeu C., Massague J., and Letarte M. Endoglin is a component of the transforming growth factor β receptor system in human endothelial cells. J. Biol. Chem. 267 (1992) 19027-19030
35. Chen L.L., Dean A., Jenkinson T., and Mendelsohn J. Effect of transforming growth factor βl on proliferation and induction of hemoglobin accumulation in K-562 cells. Blood 74 (1989) 2368-2375
36. Coffey R.J., Sipes N.J., Bascom C.C., Graves-Deal R., Pennington C.Y., Weissman B.E., and Moses H.L. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res. 48 (1988) 1596-1602
37. Coletta A.A., Wakefield L.M., Howell F.V., van Roozendaal K.E., Danielpour D., Ebbs S.R., Sporn M.B., and Baum M. Anti-oestrogens induce secretion of active transformimg growth factor β in human fetal fibroblasts. Br. J. Cancer 62 (1990) 405-409
38. Cui W., Kemp C.J., Duffie E., Balmain A., and Akhurst R.J. Lack of TGF 1 expression in benign skin tumours of p53 nu11 mice is prognostic for a high risk of malignant conversion. Cancer Res. 54 (1994) 5831-5836
39. Cui W., Fowlis D.J., Cousins F.M., Duffie E., Bryson S., Balmain A., and Akhurst R.J. Concerted action of TGFβ 1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes and Dev. 9 (1995) 945-955
40. Curtsinger L.J., Petsch J.D., Brown G.L., von Fraunhofer A., Ackerman D., Polk H.C.J., and Schultz G.S. Reversal of adriamycin-impaired wound healing by transforming growth factor β. Surg. Bynecol. Obstet. 168 (1989) 517-522
41. Czarniecki C.W., Chiu H.H., Wong G.H.W., McCabe S.M., and Palladino M.A. Transforming growth factor βl modulates the expression of class II histocompatability antigens on human cells. J. Immunol. 140 (1988) 4217-4223
42. Daopin S., Piez K.A., Ogawa Y., and Davie D.R. Crystal structure of transforming growth factor β2 an unusual fold for the superfamily. Science 257 (1992) 369-373
43. Denhez F., Lafayatis R., Kondaiah P., Roberts A.B., and Sporn M.B. Cloning by polymerase chain reaction of a new mouse TGF-β, mTGF-β3. Growth Factors 3 (1990) 139-146
44. Dennis P.A., and Rifkin D.B. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 88 (1991) 580-584
45. Derynck R., Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Sporn M.B., and Goeddel D.V. Human transforming growth factor β cDNA sequence and expression in tumor cell lines. Nature 316 (1985) 701-705
46. Derynck R., Goeddel D.V., Ullrich A., Gutterman J.U., Williams R.D., Bringman T.S., and Berger W.H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47 (1987) 707-712
47. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., and Akhurst R.J. Transforming growth factor-beta 1 is essential for hematopoiesis and endothelial differentiation in vivo. Development 121 (1995) 1845-1854
48. Esherick J.S., DiCunto F., Flanders K.C., Missero C., and Dotto G.P. Transforming growth factor βl induction is associated with TGF-β2 and β3 downmodulation in TPA-induced skin hyperplasia. Cancer Res. 53 (1993) 5517-5522
49. Espevik T., Figari I.S., Ranges G.E., and Palladino M.A.J. Transforming growth factor βl (TGF-βl) and recombinant human tumor necrosis factor-α reciprocally regulate the generation of lymphokine-activated killer cell activity Comparison between natural porcine platelet-derived TGF-βl and TGF-β 2, and recombinant human TGF-βl. J. Immunol. 140 (1988) 2312-2316
50. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
51. Fiorelli G., Ballock R.T., Wakefield L.M., Sporn M.B., Gori F., Masi L., Frediani U., Tanini A., Bernabei P.A., and Brandi M.I. Role for autocrine TGF-βl in regulating differentiation of a human leukemic cell line toward osteoclast-like cells. J. Cell. Physiol. 160 (1994) 482-490
52. Fitzpatrick D.R., Denhez F., Kondaiah P., and Akhurst R.J. Differential expression of TGF-β isoforms in murine palatogenesis. Development 109 (1990) 585-595
53. Flanders K.C., Thompson N.L., Cissel D.S., Van Obberghen S.E., Baker C.C., Kass M.E., Ellingsworth L.R., Roberts A.B., and Sporn M.B. Transforming growth factor βl: Histochemical localization with antibodies to different epitopes. J. Cell Biol. 108 (1989) 653-660
54. Flaumenhaft R., Abe M., and Rifkin D.B. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity. J. Cell Biol. 118 (1992) 901-909
55. Flaumenhaft R., Abe M., Sato Y., Miyazono K., Harpel J., Heldin C., and Rifkin D.B. Role of latent TGF-β binding protein in the activation of latent TGF-β by cocultures of endothelial and smooth muscle cells. J. Cell Biol. 120 (1993) 995-1002
56. Florini J.R., Roberts A.B., Ewton D.Z., Falen S.L., Flanders K.C., and Sporn M.B. Transforming growth factor β A very potent inhibitor of myoblast differentiation identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J. Biol. Chem. 261 (1986) 16509-16513
57. Fowlis D.J., Flanders K., Duffie E., Balmain A., and Akhurst R.J. Discordant TGFβl RNA and protein localizations during chemical carcinogenesis of the skin. Cell Growth Differentiation 3 (1992) 81-91
58. Frolik C.A., Dart L.L., Meyers C.A., Smith D.M., and Sporn M.B. Purification and initial characterization of a type β transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA 80 (1983) 3676-3680
59. Fujii D., Brissenden J.E., Derynck R., and Francke U. Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat. Cell Mol. Genet. 12 (1986) 281-288
60. Gamble J.R., and Vadas M.A. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor β. Science 242 (1988) 97-99
61. Gamble J.R., and Vadas M.A. Endothelial cell adhesiveness for human T-lymphocytes is inhibited by transforming growth factor βl. J. Immunol. 146 (1991) 1149-1154
62. Gatherer D., ten Dijke P., Baird D.T., and Akhurst R.J. Expression of TGFβ isoforms during first trimester human embryogenesis. Development 110 (1990) 445-460
63. Geiser A.G., Kim S., Roberts A.B., and Sporn M.B. Characterization of the mouse transforming growth factor βl promoter and activation by the Ha-ras oncogene. Mol. Cell. Biol. 11 (1991) 84-92
64. Geiser A., Letterio J.J., Kulkarni A.B., Karlsson S., Roberts A.B., and Sporn M.B. TGF-βl controls expression of major histocompatibility genes in the postnatal mouse: Aberrant histocom-patibility antigen expression in the pathogenesis of the TGFβl null phenotype. Proc. Natl. Acad. Sci. USA 90 (1993) 994
65. Gentry L.E., Webb N.R., Lim G.J., Brunner A.M., Ranchalis J.E., Twardzik D.R., Lioubin M.N., Marquardt H., and Purchio A.F. Type 1 transforming growth factor β: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells. Mol. Cell Biol. 7 (1987) 3418-3427
66. Gentry L.E., and Nash B.W. The pro domain of pre-pro-transforming growth factor βl when independently expressed is a functional binding protein for the mature growth factor. Biochem. 29 (1990) 6851-6857
67. Glaser B.M., Michels R.G., Kuppermann B.D., Sjaarda R.N., and Pena R.A. Transforming growth factor β2 for the treatment of full-thickness macular holes. Ophthalmology 99 (1992) 1162-1173
68. Glick A.B., Flanders K.C., Danielpour D., Yuspa S.H., and Sporn M.B. Retinoic acid induces transforming growth factor β2 in cultured keratinocytes and mouse epidermis. Cell Regul. 1 (1989) 87-97
69. Glick A.B., Kulkarni A.B., Tennenbaum T., Hennings H., Flanders K.C., O'Reilly M., Sporn M.B., Karlsson S., and Yuspa S.H. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA 90 (1993) 6076-6080
70. Glick A.B., Lee M.M., Darwiche N., Kulkarni A.B., Karlsson S., and Yuspa S.H. Targeted deletion of the TGF-βl gene causes rapid progression to squamous cell carcinoma. Genes Dev. 8 (1994) 2429-2440
71. Gorsch S.M., Memoli V.A., Stukel T.A., Gold L.I., and Arrick B.A. Immunohistochemical staining for transforming growth factor βl associates with disease progression in human breast cancer. Cancer Res. 52 (1992) 6949-6952
72. Gray S.M., and Mason A.J. Requirement for activin A and transforming growth factor β pro-region in homodimer assembly. Science 247 (1990) 1328-1330
73. Graycar J.L., Miller D.A., Arrick B.A., Lyons R.M., Moses H.L., and Derynck R. Human transforming growth factor β3: Recombinant expression, purification, and biological activities in comparison with transforming growth factors βl and β2. Mol. Endocrinol. 3 (1989) 1977-1986
74. Greenhalgh D.A., Rothnagel J.A., Quintanilla M.I., Orengo C.C., Gagne T.A., Bundman D.S., Longley M.A., and Roop D.R. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinogen. 7 (1993) 99-110
75. Haddow S., Fowlis D.J., Parkinson K., Akhurst R.J., and Balmain A. Loss of growth control by TGFβ occurs at a late stage of mouse carcinogenesis and is independent of ras gene activation. Oncogene 6 (1991) 1465-1470
76. Heimark R.L., Twardzik D.R., and Schwartz S.M. Inhibition of endothelial regeneration by type β transforming growth factor from platelets. Science 233 (1986) 1078-1080
77. Heino J., and Massague J. Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J. Biol. Chem. 36 (1989) 21806-21811
78. Hennings H., Spangler E.F., Shores R., Mitchell P., Devor D., Shamsuddin A.K.M., Elgjo K.M., and Yuspa S.H. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6 (1985) 1607-1610
79. Hines K.L., Kulkarni A.B., McCarthy J.B., Tian H., Ward J.M., Christ M., McCartney-Francis L., Furcht L.T., Karlsson S., and Wahl S.M. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor βl knockout mice. Proc. Natl. Acad. Sci. USA 91 (1994) 5187-5191
80. Hsu S., Huang F., Hafez M., Winawer S., and Friedman E. Colon carcinoma cells switch their response to transforming growth factor βl with tumor progression. Cell Growth Differentiation 5 (1994) 267-275
81. Hubbs A.F., Hahn F.F., and Thomassen D.G. Increased resistance to transforming growth factor β accompanies neoplastic progression of rat tracheal epithelial cells. Carcinogenesis. 10 (1989) 1599-1605
82. Ignotz R.A., and Massague J. Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261 (1986) 4337-4345
83. Ignotz R.A., Heino J., and Massague J. Regulation of cell adhesion receptors by transforming growth factor β Regulation of vitronectin receptor and LFA-1. J. Biol. Chem. 264 (1989) 389-392
84. Jennings J.C., Mohan S., Linkhart T.A., Widstrom R., and Baylink D.J. Comparison of the biological actions of TGF-βl and TGF-β2: Differential activity in endothelial cells. J. Cell Physiol. 137 (1988) 167-172
85. Jhappan C., Geiser A.G., Kordon E.C., Bagheri D., Hennighausen L., Roberts A.B., Smith G.H., and Merlino G. Targeting expression of a transforming growth factor βl transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J. 12 (1993) 1835-1845
86. Johns L.D., Flanders K.C., Ranges G.E., and Sriram S. ) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor βl. J. Immunol. 147 (1991) 1792-1796
87. Jones S.C., Curtsinger L.J., Whalen J.D., Pietsch J.D., Ackerman D., Brown G.L., and Schultz G.S. Effect of topical recombinant TGF-β on healing of partial thickness injuries. J. Surg. Res. 51 (1991) 344-352
88. Joyce M.E., Roberts A.B., Sporn M.B., and Nolander M.E. Transforming growth factor β and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110 (1990) 2195-2207
89. Jürgensmeier J.M., Schmitt C.P., Viesel E., Höfler P., and Bauer G. Transforming growth factor β-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res. 54 (1994) 393-398
90. Kaartinen V., Voncken J.W., Shuler C., Warburton D., Bu D., Heisterkamp N., and Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nature Gen. 11 (1995) 415-421
91. Kane C.J., Hebda P.A., Mansbridge J.N., and Hanawalt P.C. Direct evidence for spatial and temporal regulation of transforming growth factor βl expression during cutaneous wound healing. J. Cell Physiol. 148 (1991) 157-173
92. Kanzaki T., Olofsson A., Moren A., Wernstedt C., Hellman U., Miyazono K., Claesson-Welsh L., and Heldin C. TGF-β 1 binding protein: A component of the large latent complex of TGF-β 1 with multiple repeat sequences. Cell 61 (1990) 1051-1061
93. Kato Y., Iwamoto M., Koike T., Suzuki F., and Takano Y. Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: Regulation by transform-ing growth factor β and serum factors. Proc. Natl. Acad. Sci. USA 85 (1988) 9552-9556
94. Kehrl J.H., Roberts A.B., Wakefield L.M., Jakowlew S., and Sporn M.B. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137 (1986) 3855-3860
95. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez Mon.M., Derynck R., Sporn M.B., and Fauci A.S. Production of transforming growth factor β by human T-lymphocytes and its potential role in the regulation of T-cell growth. J. Exp. Med. 163 (1986) 1037-1050
96. Kehrl J.H., Thevenin C., Rieckmann P., and Fauci A.S. Transforming growth factor β suppresses human B-lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J. Immun. 146 (1991) 4016-4023
97. Keller J.R., Jaconsen S.E.W., Sill K., Ellingsworth L., and Ruscetti F.W. Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad Sci. USA 88 (1991) 7190-7193
98. Keller J.R., Bartelmez S.H., Sitnicka E., Ruscetti F.W., Mariaestella O., Gooya J.M., and Jacobsen S.E.W. Distinct and overlapping direct effects of macrophage inhibitory protein-1 αand transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood 84 (1994) 2175-2181
99. Kemp C.J., Donehower L.A., Bradley A., and Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but greatly enhances malignant progression of chemically induced skin tumours. Cell 74 (1993) 813-822
100. Kim S., Glick A., Sporn M.B., and Roberts A.B. Characterization of the promoter region of the human transforming growth factor βl gene. J. Biol. Chem. 264 (1989) 402-408
101. Kim S., Park K., Koeller D., Kim K.Y., Wakefield L.M., Sporn M.B., and Roberts A.B. Posttranscriptional regulation of the transforming growth factor βl gene. J. Biol. Chem. 267 (1992) 13702-13707
102. Kingsley D.M. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8 (1994) 133-146
103. Kojima S., Nara K., and Rifkin D.B. Requirement for transglutaminase in the activation of latent transforming growth factor β in bovine endothelial cells. J. Cell Biol. 121 (1993) 439-448
104. Kondaiah P., Sands M.J., Smith J.M., Fields A., Roberts A.B., Sporn M.B., and Melton D.A. Identification of a novel transforming growth factor β (TGFβ5) mRNA in Xenopus laevis. J. Biol. Chem. 265 (1990) 1089-1093
105. 393-03. Kovacina K.S., Steele Perkins G., Purchio A.F., Lioubin M., Miyazono K., Heldin C.H., and Roth R.A. Interactions of recombinant and platelet-transforming growth factor βl precursor with the insulin-like growth factor II/mannose-6-phosphate receptor. Biochem. Biophys. Res. Commun. 160 (1989)
106. Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15 (1987) 8125-8147
107. Krieg P., Schnapke R., Furstenberger G., Vogt I., and Marks F. TGF-β 1 and skincarcinogenesis: Antiproliferative effect in vitro and TGF-β 1 mRNA during epidermal hyperproliferation and multistage tumorigenesis. Molecular Carcinogen. 4 (1991) 129-137
108. Krummel T.M., Michna B.A., Thomas B.L., Sporn M.B., Nelson J.M., Salzberg A.M., Cohen I.K., and Diegelmann R.F. Transforming growth factor β (TGF-β) induces fibrosis in a fetal wound model. J. Pediatr. Surg. 23 (1988) 647-652
109. Ksander G.A., Ogawa Y., Chu G.H., McMullin H., Rosenblatt J.S., and McPherson J.M. Exogenous transforming growth factor β2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. Ann. Surg. 211 (1990) 288-294
110. Kulkarni A.B., Huh C., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., and Karlsson S. Transforming growth factor βl null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90 (1993) 770-774
111. Kulkarni A.B., and Karlsson S. Transforming growth factor βl (TGF-β 1) knockout mice: A mutation in one cytokine causes dramatic inflammatory disease. Am. J. Pathol. 143 (1993) 3-9
112. Kulkarni A.B., Ward J.M., Geiser A.G., Letterio J.J., Hines K.L., Christ M., D'Souza R.N., Huh C., Roberts A.B., Sporn M.B., McCartney-Francis N., Wahl S.M., Glick A.B., Yuspa S.H., Mackall C., Gress R.E., and Karlsson S. TGFβl knockout mice: Immune dysregulation and pathology, 8th Symposium on molecular biology of hematopoiesis. In: Abrahm N.G., Shadduck R.K., Levine A.S., and Takaku F. (Eds). Molecular Biology of Haematopoiesis Vol. 3 (1994), Intercept Ltd, Andover, NH. 749-757
113. Kulkarni A.B., Ward J.M., Yaswen L., Mackall C.L., Bauer S.R., Huh C.G., Gress R.E., and Karisson S. Transforming growth factor β 1 null mice: An animal model for inflammatory disorders. Am. J. Pathol. 146 (1995) 1-12
114. Kuruvilla A.P., Shah R., Hochwald G.M., Uggitt H.D., Palladino M.A., and Thorbecke G.J. Protective effect of transforming growth factor β 1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 88 (1991) 2918-2921
115. Kyprianou N., and Isaacs J.T. Expression of transforming growth factor in the rat ventral prostate during castration-induced programmed cell death. Mol. Endocrinol. 3 (1989) 1515-1522
116. Lafyatis R., Lechleider R., Kim S., Jakowlew S., Roberts A.B., and Sporn M.B. Structural and functional characterisation of the transforming growth factor β3 promoter. J. Biol. Chem. 265 (1990) 19128-19136
117. Letterio J.J., Gieser A.G., Kulkarni A.B., Roche N.S., Sporn M.B., and Roberts A.B. Maternal rescue of the transforming growth factor β knockout. Science 264 (1994) 1936-1938
118. Levine J.H., Moses H.L., Gold L.I., and Nanney L.B. Spatial and temporal patterns of immunoreactive transforming growth factor βl, β2, and β3 during excisional wound repair. Am. J. Pathol. 143 (1993) 368-380
119. Li M.L., Aggeler J., Farson D.A., Hatier C., Hassell J., and Bissell M.J. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. USA 84 (1987) 136-140
120. Lin H.Y., Wang X., Ng E.E., Weinberg R.A., and Lodish H.F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68 (1992) 775-785
121. Lin J., and Chou C. In Vitro apoptosis in the human hepatoma cell line induced by transforming growth factor βl. Cancer Res. 52 (1992) 385-388
122. Lindholm D., Castrén E., Kiefer R., Zafran F., and Thoenen H. Transforming growth factor βl in the rat brain: Increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117 (1992) 395-400
123. Lopez A.R., Cook J., Deininger P.L., and Derynck R. Dominant negative mutants of transforming growth factor βl inhibit the secretion of different transforming growth factor β isoforms. Mol. Cell. Biol. 12 (1992) 1674-1679
124. Lyons R.M., Gentry L.E., Purchio A.F., and Moses H.L. Mechanism of activation of latent recombinant transforming growth factor βl by plasmin. J. Cell Biol. 110 (1990) 1361-1367
125. Madisen L., Lioubin M.N., Marquardt H., and Purchio A.F. High-level expression of TGF-β2 and the TGF-β2 (414) precursor in Chinese hamster ovary cells. Growth factor 3 (1990) 129-138
126. Madri J.A., Williams S.K., Wyatt T., and Mezzio C. Capillary endothelial cell cultures: Phenotypic modulation by matrix components. J. Cell Biol. 97 (1983) 153-165
127. Madri J.A., Pratt B.M., and Tucker A.M. Phenotypic modulation of endothelial cells by transforming growth factor β depends upon the composition and organization of the extracellular matrix. J. Cell Biol. 106 (1988) 1375-1384
128. Madri J.A., Bell L., and Merwin J.R. Modulation of vascular cell behavior by transforming growth factors β. Mol. Reprod. Dev. 32 (1992) 121-126
129. Manning A.M., Williams A.C., Games S.M., and Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGFβ) : Conver-sion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGFβ. Oncogene 6 (1991) 1471-1476
130. Mansbridge J.N., and Hanawalt P.C. Role of transforming growth factor β in the maturation of human epidermal keratinocytes. J. Invest. Dermatol. 90 (1988) 336-341
131. Martin P., Dickson M.C., Millan F.A., and Akhurst R.J. Rapid induction and clearance of TGFβl is an early response to wounding in the mouse embryo. Dev. Genet. 14 (1993) 225-236
132. Maslen C.L., Corson G.M., Maddox B.K., Glanville R.W., and Sakai L.Y. Partial sequence of a candidate gene for the Marfan syndrome. Nature 352 (1991) 334-337
133. Massague J., Cheifetz S., Endo T., and Nadal-Ginard B. Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83 (1986) 8206-8210
134. Massague J. The transforming growth factor β family. Ann. Rev. Cell Biol. 6 (1990) 597-641
135. Massague J., Cheifetz S., Boyd F.T., and Andres J.L. TGF β receptors and TGFβ binding proteoglycans: Recent progress in identifying their functional properties. Ann. NY Acad. Sci. USA 593 (1990) 59-72
136. Massague J. Receptors for the TGFβ family. Cell 69 (1992) 1067-1070
137. Massague J., Cheifetz S., Laiho M., Ralph D.A., Weis F.M.B., and Zentella A. Transforming growth factor β. Cancer Surv. 12 (1992) 81-103
138. Masui T., Wakefield L.M., Lechner J.F., LaVeck M.A., Sporn M.B., and Harris C.C. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83 (1986) 2438-2442
139. Matsumoto K., Hashimoto K., Hashiro M., Yoshimasa H., and Yoshikawa K. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor β. J. Cell. Physiol. 145 (1990) 95-101
140. McAllister K.A., Grogg D.W., Johnson D.W., Gallione C.J., Baldwin M.A., Jackson C.E., Helmbold E.A., Markel D.S., McKinnon W.C., Murrell J., McCormick M.K., Pericak-Vance M.A., Heutink P., Oostra B.A., Haitjema T., Westerman C.J.J., Porteous M.E., Guttmacher A.E., Letarte M., and Marchuk D.A. Endoglin, a TGFβ binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nature Genet. 8 (1994) 345-351
141. McDonald N.Q., and Hendrickson W.A. A structural superfamily of growth factors containing a cystine knot motif. Cell 73 (1993) 421-424
142. Merwin J.R., Anderson J., Kocher O., van Itallie C., and Madri J.A. Transforming growth factor β modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J. Cell Physiol. 142 (1990) 117-128
143. Merwin J.R., Newman W., Beall D., Tucker A., and Madri J.A. Vascular cells respond differentially to transforming growth factors βl and β2. Am. J. Pathol. 138 (1991) 37-51
144. Millan F.A., Kondaiah P., Denhez F., and Akhurst R.J. Embryonic gene expression patterns of TGF-βl, 2, and 3 suggest different developmental functions in vivo. Development 111 (1991) 131-144
145. Miller D.M., Ogawa Y., Iwata K.K., ten Dijke P., Purchio A.F., Soloff M.S., and Gentry L.E. Characterization of the binding of transforming growth factor βl, β2, and β3 to recombinant β 1-latency-associated peptide. Mol. Endocrinol. 6 (1992) 694-702
146. Miyazono K., Hellman U., Wernstedt C., and Heldin C.H. Latent high molecular weight complex of transforming growth factor βl Purification from human platelets and structural characterization. J. Biol. Chem. 263 (1988) 6407-6415
147. Miyazono K., and Heldin C.H. Role for carbohydrate structures in TGFβl latency. Nature 338 (1989) 158-160
148. Miyazono K., Olofsson A., Colosetti P., and Heldin C. A role of the latent TGFβl-binding protein in the assembly and secretion of TGFβl. EMBO J. 10 (1991) 1091-1101
149. Miyazono K., Ichijo H., and Heldin C. Transforming growth factor β: Latent forms, binding proteins, and receptors. Growth Factors 8 (1993) 11-22
150. Moses H.L., Branum E.L., Proper J.A., and Robinson R.A. Transforming growth factor production by chemically transformed cells. Cancer Res. 41 (1981) 2842-2848
151. Moses H.L., Tucker R.F., Leof E.B., Coffey R.J., Halper J., and Shipley G.D. Type β transforming growth factor is a growth stimulator and a growth inhibitor. In: Feramisco J., Ozanne B., and Stiles C. (Eds). Cancer Cells (1985), Cold Spring Harbor Laboratory, New York 65-71
152. Moulton B.C. Transforming growth factor β stimulates endometrial stromal apoptosis in vitro. Endocrinol 134 (1994) 1055-1060
153. Muller G., Behrens J., Nussbaumer U., Bohlen P., and Birchmeier W. Inhibitory action of transforming growth factor β on endothelial cells. Proc. Natl. Acad. Sci. USA 84 (1987) 5600-5604
154. Mustoe T.A., Pierce G.F., Thomason A., Gramates P., Sporn M.B., and Deuel T.F. Accelerated healing of incisional wounds in rats induced by transforming growth factor β. Science 237 (1987) 1333-1336
155. Mustoe T.A., Landes A., Cromack D.T., Mistry D., Griffin A., Deudl T.F., and Pierce G.F. Differential acceleratiion of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type β. Surgery 108 (1990) 324-329
156. Noda M., and Rodan G.A. Type β transforming growth factor (TGFβ) regulation of alkaline phosphatase expression, and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J. Cell Physiol. 133 (1987) 426-437
157. Noma T., Glick A.B., O'Reilly M.A., Miller J., Roberts A.B., and Sporn M.B. Molecular cloning and structure of the human transforming growth factor β2 gene promoter. Growth Factors 4 (1991) 247-255
158. Nugent M.A., and Edelman E.R. Transforming growth factor βl stimulates the production of basic fibroblast growth factor-binding proteoglycans in Balb/c3t3 cells. J. Biol. Chem. 267 (1992) 21256-21264
159. O'Reilly M.A., Geiser A.G., Kim S., Bruggeman L.A., Luu A.X., Roberts A.B., and Sporn M.B. Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor β2 promoter. J. Biol. Chem. 267 (1992) 19938-19943
160. Oberhammer F., Bursch W., Parzefall W., Breit P., Erber E., Stadler M., and Schulte-Hermann R. Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res. 51 (1991) 2478-2485
161. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W., and Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor βl. Proc. Natl. Acad. Sci. USA 89 (1992) 5408-5412
162. Ohta M., Greenberger J.S., Anklesaria P., Bassols A., and Massague J. Two forms of transforming growth factor β distinguished by multipotential haematopoietic progenitor cells. Nature 329 (1987) 539-541
163. Olson E.N., Sternberg E., Hu J.S., Spizz G., and Wilcox C. Regulation of myogenic differentiation by type β transforming growth factor. J. Cell Biol. 103 (1986) 1799-1805
164. Ortaldo J.R., Mason A.T., Oshea J.J., Smyth M.J., Falk L.A., Kennedy I.C.S., Longo D.L., and Ruscetti F.W. Mechanistic studies of transforming growth factor β inhibition of IL-2-dependent activation of CD-3 large granular lymphocyte functions: Regulation of IL-2Rβ (p75) signal transduction. J. Immun. 146 (1991) 3791-3798
165. Parkinson K., and Balmain A. Chalones revisited-a possible role for TGFβ in tumor promotion. Carcinogenesis 20 (1990) 195-198
166. Pelton R.W., Hogan B.L., Miller D.A., and Moses H.L. Differential expression of genes encoding TGFs βl, β2, and β3 during murine palate formation. Developmental Biology 141 (1990) 456-460
167. Pelton R.W., Saxena B., Jones M., Moses H.L., and Gold L.I. Immunohistochemical localization of TGFβ 1, TGFβ2, and TGFβ3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115 (1991) 1091-1105
168. Perrella M.A., Yoshizumi M., Fen Z., Tsai J., Hsieh C., Kourembanas S., and Lee M. Transforming growth factor βl, but not dexamethasone, downregulates nitric oxide synthase mRNA after its induction by interleukin-1 β in rat smooth muscle cells. J. Biol. Chem. 269 (1994) 14595-14600
169. Pierce G.F., Mustoe T.A., Lingelbach J., Masakowski V.R., Gramates P., and Deuel T.F. Transforming growth factor β reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor, Proc. Natl. Acad. Sci. USA 86 (1989) 2229-2233
170. Pierce D.F.J., Johnson M.D., Matsui Y., Robinson S.D., Gold L.I., Purchio A.F., Daniel C.W., Hogan B.L.M., and Moses H.L. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-βl. Genes Dev. 7 (1993) 2308-2317
171. Pircher R., Jullien P., and Lawrence D.A. β-Transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. Biophys. Res. Commun. 136 (1986) 30-37
172. Prehn J.H.M., Peruche B., Unsicker K., and Krieglstein J. Transforming growth factor βl prevents degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60 (1993) 1665-1672
173. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howies P.N., Ding J., Ferguson M.J., and Doetschman T. Transforming growth factor-β3 is required for secondary palate fusion. Nature Gen. 11 (1995) 409-414
174. Qian S.W., Burmester J.K., Merwin J.R., Madri J.A., Sporn M.B., and Roberts A.B. Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor β on endothelial cells. Proc. Natl. Acad. Sci. USA 89 (1992) 6290-6294
175. Quaglino D., Nanney L.B., Ditesheim J.A., and Davidson J.M. Transforming growth factor β stimulates wound healing and modulates extracellular matrix gene expression in pig skin incisional wound model. J. Invest. Dermatol. 97 (1991) 34-42
176. Reiss M., and Sartorelli A.C. Regulation of growth and differentiation of human keratinocytes by type β transforming growth factor and epidermal growth factor. Cancer Res. 47 (1987) 6705-6709
177. Ristow H.J. BSC-1 growth inhibitor/type β transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc. Natl. Acad. Sci. USA 83 (1986) 5531-5533
178. Roberts A.B., Anzano M.A., Lamb L.C., Smith J.M., and Sporn M.B. New class of transforming growth factors potentiated by epidermal growth factor. Proc. Natl. Acad. Sci. USA 78 (1981) 5339-5343
179. Roberts A.B., Anzano M.A., Meyer C.A., Wideman J., Blacher R., Pan Y., Stein S., Lehrman S.R., Smith J.M., Lamb L.C., and Sporn M.B. Purification and properties of a type β transforming growth factor from bovine kidney. Biochem. 22 (1983) 5692-5698
180. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., Heine U.I., Liotta L.A., Falanga V., Kehrl J.H., et al. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83 (1986) 4167-4171
181. Roberts A.B., and Sporn M.B. The transforming growth factor βs. In: Sporn M.B., and Roberts A.B. (Eds). Peptide Growth Factors and Their Receptors-Handbook of Experimental Pharmacology (1990), Springer-Verlag, Heidelberg 419-472
182. Roberts A.B., Vodovotz Y., Roche N.S., Sporn M.B., and Nathan C.F. Role of nitric oxide in antagonistic effects of transforming growth factor β and interleukin-1 β on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 6 (1992) 1921-1930
183. Robinson S.D., Silberstein G.B., Roberts A.B., Flanders K.C., and Daniel C.W. Regulated expression and growth inhibitory effects of transforming growth factor β isoforms in mouse mammary gland development. Development 113 (1991) 867-878
184. Romeo D.S., Park K., Roberts A.B., Sporn M.B., and Kim S. An element of the transforming growth factor βl 5'-untranslated region represses translation and specifically binds a cytosolic factor. Mol. Endocrinol. 7 (1993) 759-766
185. Rook A.H., Kehrl J.H., Wakefield L.M., Roberts A.B., Sporn M.B., Burlington D.B., Lane H.C., and Fauci A.S. Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136 (1986) 3916-3920
186. Rosa F., Roberts A.B., Danielpour D., Dart L.L., Sporn M.B., and Dawid I.B. Mesoderm induction in amphibians: The role of TGF-β2-like factors. Science 239 (1988) 783-785
187. Ross N.R., and Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol. Today 14 (1993) 426-430
188. Rotello R.J., Leiberman R.C., Purchio A.F., and Gerschenson L.E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β 1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA 88 (1991) 3412-3415
189. Russell W.E., Coffey Jr. R.J., Ouellette A.J., and Moses H.L. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 85 (1988) 5126-5130
190. Salomon G.D., Kasid A., Bernstein E., Buresh C., Director E., and Norton J.A. Gene expression in normal and doxorubicin-impaired wounds: Importance of transforming growth factor β. Surgery 108 (1990) 318-322
191. Samuel S.K., Hurta R.A.R., Kondaiah P., Khalil N., Turley E.A., Wright J.A., and Greenberg A.H. Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-βl. EMBO J 11 (1992) 1599-1605
192. Sato Y., and Rifkin D.B. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor β1-like molecule by plasmin during coculture. J. Cell Biol. 109 (1989) 309-315
193. Schlunegger M.P., and Grutter M.G. An unusual feature revealed by the crystal structure at 2.2A resolution of human transforming growth factor β2. Nature 258 (1992) 430-434
194. Scotto L., and Assoian R.K. A GC-rich domain with bifunctional effects on mRNA and protein levels: Implications for control of transforming growth factor βl expression. Mol. Cell. Biol. 13 (1993) 3588-3597
195. Sellheyer K., Bickenbach J.R., Rothnagel J.A., Bundman D., Longley M.A., Krieg T., Roche N.S., Roberts A.B., and Roop D.R. Inhibition of skin development by overexpression of transforming growth factor βl in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. USA 90 (1993) 5237-5241
196. Sha X., Yang L., and Gentry L.E. Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor βl. J. Cell Biol. 114 (1991) 827-839
197. Shah M., Foreman D.M., and Ferguso M.W.J. Control of scarring in adult wounds by neutralizing antibody to TGFβ. Lancet 339 (1992) 213-214
198. Sherman J.H., Miller M., Albert R.E., and Baxter S. Dose-and time-dependent expression of transforming growth factor β1 mRNA and protein in mouse epidermis and papillomas after repeated topical application of benzo[a]pyrene. Mol. Carcinog. 8 (1993) 264-271
199. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., and Doetschman T. Targeted disruption of the mouse transforming growth factor βl gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
200. Shull M.M., and Doetschman T. Transforming growth factor β1 in reproduction and develop-ment. Mol. Reprod. Devel. 39 (1994) 239-246
201. Silberstein G.B., and Daniel C.W. Reversible inhibition of mammary gland growth by transforming growth factor β. Science 237 (1987) 291-293
202. Slavin J., Nash J.R., and Kingsnorth A.N. Effect of transforming growth factor β and basic fibroblast growth factor on steroid-impaired healing intestinal wounds. Br. J. Surg. 79 (1992) 69-72
203. Sporn M.B., Roberts A.B., Shull J.H., Smith J.M., Ward J.M., and Sodek J. Polypeptide transforming growth factors: Isolation from bovine sources and use for wound healing in vivo. Science 219 (1983) 1329-1331
204. Sporn M.B., and Roberts A.B. Autocrine growth factors and cancer. Nature (Lond.) 313 (1985) 745-747
205. Sporn M.B., and Roberts A.B. Transforming growth factor β: Recent progress and new challenges. J. Cell Biol. 119 (1992) 1017-1021
206. Suardet L., Gaide A., Calmes J., Sordat B., Givel J., Eliason J.F., and Odartchenko N. Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors β1 and β2. Cancer Res. 52 (1992) 3705-3712
207. ten D.P., Geurts v.K.A.H.M., Foulkes J.G., and Le B.M.M. Transforming growth factor type β3 maps to human chromosome 14, region q23-q24. Oncogene 3 (1988) 721-724
208. Torre-Amione G., Beauchamp R.D., Koeppen H., Park B.H., Schreiber H., Moses H.L., and Rowley D.A. A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA 87 (1990) 1486-1490
209. Torti F.M., Torti S.V., Larrick J.W., and Ringold G.M. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor β. J. Cell Biol. 108 (1989) 1105-1113
210. Tsuji T., Okada F., Yamaguchi K., and Nakamura T. Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various tissues. Proc. Natl. Acad. Sci. USA 87 (1990) 8835-8839
211. Valverius E.M., Walker-Jones D., Bates S.E., Stampfer M.R., Clark R., McCormick F., Dickson R.B., and Lippman M.E. Production of and responsiveness to transforming growth factor β in normal and oncogene-transformed human mammary epithelial cells. Cancer Res. 49 (1989) 6269-6274
212. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., and Sporn M.B. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84 (1987) 5788-5792
213. Wahl S.M., Hunt D.A., Wong H.L., Dougherty S., McCartney-Francis N., Ellingsworth L., Schmidt J.A., Hall G., Roberts A.B., et al. Transforming growth factor β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140 (1988) 3026-3032
214. Wahl S.M. Transforming growth factor β (TGFβ) in inflammation: A cause and a cure. J. Clin. Immunol. 12 (1992) 61-74
215. Welch D.R., Fabra A., and Nakajima M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA 87 (1990) 7678-7682
216. Whitby D.J., and Ferguson M.W.J. The extracellular matrix of lip wounds in feral, neomatal, and adult mice. Development 112 (1991) 651-668
217. Wu S.P., Theodoresou D., Kerbel R.S., Willson J.K., Mulder K.M., Humphrey L.E., and Brattain M.G. TGFβl is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol. 116 (1992) 187-196
218. Wyllie A.H. The biology of cell death in tumors. Anticancer Res. 5 (1985) 131-136
219. Yang E.Y., and Moses H.L. Transforming growth factor βl-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111 (1990) 731-741
220. Yuspa S.H. The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis-33rd G.H.A, Clowes Memorial Award Lecture. Cancer Res. 54 (1994) 1178-1189
221. Zentrella A., and Massague J. Transforming growth factor β induces myoblast differentiation in the presence of mitogens. Proc. Natl. Acad. Sci. USA 89 (1992) 5176-5180
222. Zugmaier G., Ennis B.W., Deschauer B., Katz D., Knabbe C., Wilding G., Daly P., Lippman M.E., and Dickson R.B. Transforming growth factors type βl and β2 are equipotent growth inhibitors of human breast cancer cell lines. J. Cell. Physiol. 141 (1989) 353-361
223. Zugmaier G., and Lippman M.E. Effects of TGF-β on normal and malignant mammary epithelium. Ann. NY. Acad. Sci. 593 (1990) 272-275